Saccharomyces cerevisiae I-3856 in irritable bowel syndrome with predominant constipation

Figure 5 Irritable bowel syndrome-specific quality of life questionnaire scores at the end of the intervention (V3) adjusted to baseline (V1) in ITT abdominal pain responders supplemented with Saccharomycescerevisiae CNCM I-3856. PP population radar plot: Supplementary Figure 3. Significant result (^aP < 0.05, ANCOVA for repeated measures). Between-group differences are shown in Supplementary Table 2.